EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1
EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1
Active Implantable Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007
This list contains hazardous substances for purposes of Directive 90/385/EEC on active implantable medical devices, particularly as regards Article 3 and Annex I (Essential Requirements). This non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 90/385/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.
Last updated 16 May 2024. Database contains 4753 unique substances/entries.
Filter the list
|
231-442-4
|
7553-56-2
|
Acute Tox. 4 |
|||
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
605-683-4
|
173584-44-6
|
Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B |
|||
|
244-959-5
|
22398-80-7
|
Carc. 1B; Repr. 2; STOT RE 1 |
|||
|
428-790-6
|
72963-72-5
|
Carc. 2; Acute Tox. 4; STOT SE 2 |
|||
|
206-019-2
|
288-32-4
|
Repr. 1B; Acute Tox. 4; Skin Corr. 1C |
|||
|
431-510-5
|
18087-70-2
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
428-040-8
|
138261-41-3
|
Acute Tox. 4 |
|||
|
617-219-8
|
81334-34-1
|
Eye Irrit. 2 |
|||
|
261-351-5
|
58594-72-2
|
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
|||
|
261-351-5
|
58594-72-2
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
252-615-0
|
35554-44-0
|
Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Dam. 1 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
202-933-0
|
101-31-5
|
Acute Tox. 2 |
|||
|
200-090-3
|
51-34-3
|
Acute Tox. 2; Acute Tox. 1 |
|||
|
233-000-6
|
10004-44-1
|
Repr. 2; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1 |
|||
|
-
|
-
|
P Parasites |
|||
|
-
|
-
|
P Parasites |
|||
|
DP-3337
|
405-710-8
|
23783-26-8
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1 |
||
|
236-691-2
|
13465-08-2
|
Expl. 1.1; Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
233-154-4
|
10046-00-1
|
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
226-798-2
|
5470-11-1
|
Met. Corr. 1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
244-077-0
|
20845-01-6
|
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
242-818-2
|
19098-16-9
|
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
258-872-5
|
53933-48-5
|
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
232-259-2
|
7803-49-8
|
Met. Corr. 1; Carc. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 |
|||
|
232-259-2
|
7803-49-8
|
Unst. Expl.; Met. Corr. 1; Carc. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 |
|||
|
641-410-5
|
130066-44-3
|
Skin Sens. 1A |
|||
|
423-310-1
|
61420-92-6
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1A; Resp. Sens. 1; Skin Sens. 1 |
|||
|
SICORIN E 10197
|
403-750-0
|
113036-91-2
|
Acute Tox. 4 |
||
|
231-977-3
|
7783-06-4
|
Flam. Gas 1; Press. Gas; Acute Tox. 2 |
|||
|
2-BUTANEDIOIC ACID, MONOAMIDE WITH N-(9-OCTADECENYL)-3-AMINO
|
402-970-4
|
148292-42-6
|
Skin Sens. 1 |
||
|
231-765-0
|
7722-84-1
|
Ox. Liq. 1; Acute Tox. 4; Skin Corr. 1A |
|||
|
200-821-6
|
74-90-8
|
Flam. Liq. 1; Acute Tox. 2 |
|||
|
200-821-6
|
74-90-8
|
Acute Tox. 2; Acute Tox. 1 |
|||
|
215-605-7
|
1333-74-0
|
Flam. Gas 1; Press. Gas |
|||
|
231-634-8
|
7664-39-3
|
Acute Tox. 2; Acute Tox. 1; Skin Corr. 1A |
|||
|
231-634-8
|
7664-39-3
|
Acute Tox. 2; Acute Tox. 1; Skin Corr. 1A |
|||
|
231-595-7
|
7647-01-0
|
Skin Corr. 1B; STOT SE 3 |
|||
|
231-595-7
|
7647-01-0
|
Press. Gas; Acute Tox. 3; Skin Corr. 1A |
|||
|
A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94°C to 99°C (201°F to 210°F).
|
295-436-3
|
92045-55-1
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
297-857-8
|
93763-38-3
|
Carc. 1B |
|||
|
270-690-8
|
68476-50-6
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|||
|
A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.
|
297-854-1
|
93763-35-0
|
Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.
|
297-853-6
|
93763-34-9
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130°C to 210°C (266°F to 410°F).
|
295-794-0
|
92128-94-4
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
309-987-5
|
101896-28-0
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|||
|
A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140°C to 210°C (284°F to 410°F).
|
309-974-4
|
101794-97-2
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130°C to 205°C (266°F to 401°F).
|
295-444-7
|
92045-62-0
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120°C to 210°C (248°F to 380°F) and C9 and higher aromatic hydrocarbons.
|
297-465-7
|
93572-35-1
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65°C to 70°C (149°F to 158°F).
|
309-871-4
|
101316-67-0
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80°C to 135°C (176°F to 275°F).
|
309-870-9
|
101316-66-9
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70°C to 100°C (158°F to 212°F).
|
295-446-8
|
92045-64-2
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.
|
297-852-0
|
93763-33-8
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
270-695-5
|
68476-55-1
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|||
|
A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30°C to 170°C (86°F to 338°F).
|
310-013-6
|
102110-15-6
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35°C to 125°C (94°F to 257°F), benzene and toluene.
|
297-466-2
|
93572-36-2
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
289-339-5
|
87741-01-3
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25°C to 40°C (77°F to 104°F).
|
295-298-4
|
91995-38-9
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
270-682-4
|
68476-42-6
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30°C to 230°C (86°F to 446°F).
|
295-443-1
|
92045-61-9
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30°C to 205°C (86°F to 401°F).
|
295-445-2
|
92045-63-1
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12°C to 5°C (10.4°F to 41°F).
|
295-405-4
|
92045-23-3
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
||
|
306-004-1
|
95465-89-7
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
271-735-4
|
68606-26-8
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
305-974-3
|
95371-07-6
|
Carc. 1B |
|||
|
305-975-9
|
95371-08-7
|
Carc. 1B |
|||
|
A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.
|
310-012-0
|
102110-14-5
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
270-681-9
|
68476-40-4
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.
|
270-990-9
|
68512-91-4
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
||
|
A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204°C(400°F).
|
270-686-6
|
68476-46-0
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
308-133-9
|
97862-83-4
|
Carc. 1B |
|||
|
308-287-7
|
97926-68-6
|
Carc. 1B |
|||
|
308-290-3
|
97926-71-1
|
Carc. 1B |
|||
|
308-131-8
|
97862-81-2
|
Carc. 1B |
|||
|
308-289-8
|
97926-70-0
|
Carc. 1B |
|||
|
A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.
|
292-617-9
|
90640-95-2
|
Carc. 1B |
||
|
300-257-1
|
93924-61-9
|
Carc. 1B |
|||
|
270-687-1
|
68476-47-1
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|||
|
271-734-9
|
68606-25-7
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
270-689-2
|
68476-49-3
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100°C (212°F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300°C to 500°C (592°F to 932°F).
|
307-755-8
|
97722-06-0
|
Carc. 1B |
||
|
A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent-deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300°C to 400°C (572°F to 752°F). It produces a finished oil having a viscosity of 4cSt at approximately 100°C (212°F).
|
307-661-7
|
97675-87-1
|
Carc. 1B |
||
|
308-132-3
|
97862-82-3
|
Carc. 1B |
|||
|
305-972-2
|
95371-05-4
|
Carc. 1B |
|||
|
A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360°C to 500°C (680°F to 932°F). It produces a finished oil having a viscosity of 4.5cSt at approximately 100°C (212°F).
|
307-662-2
|
97675-88-2
|
Carc. 2 |
||
|
A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290°C to 350°C (554°F to 662°F). It produces a finished oil having a viscosity of 2cSt at 100°C (212°F).
|
307-659-6
|
97675-85-9
|
Carc. 1B |
||
|
A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40°C (104°F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250°C to 425°C (482°F to 797°F).
|
307-760-5
|
97722-10-6
|
Carc. 1B |
||
|
305-971-7
|
95371-04-3
|
Carc. 1B |
|||
|
A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40°C (104°F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240°C to 400°C (464°F to 752°F).
|
307-758-4
|
97722-09-3
|
Carc. 1B |
||
|
A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230°C to 350°C (446°F to 662°F). It produces a finished oil having a viscosity of 2cSt at 100°C (212°F).
|
307-660-1
|
97675-86-0
|
Carc. 1B |
||
|
A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 2.2cSt at 40°C (104°F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200°C to 300°C (392°F to 572°F).
|
307-757-9
|
97722-08-2
|
Carc. 1B |
||
|
A complex combination of hydrocarbons produced by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164°C to minus 0.5°C (-263°F to 31°F).
|
271-032-2
|
68514-31-8
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
||
|
A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately -164°C to -0.5°C(-263°F to 31°F).
|
271-038-5
|
68514-36-3
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
||
|
271-261-8
|
68527-19-5
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164°C to minus 42°C (-263°F to -44°F).
|
271-259-7
|
68527-16-2
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
||
|
A complex combination of hydrocarbons obtained by solvent extraction from a naphthenic distillate having a viscosity of 27cSt at 100°C (212°F). It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C26 through C55 and boiling in the range of approximately 395°C to 640°C (743°F to 1184°F).
|
307-753-7
|
97722-04-8
|
Carc. 1B |
||
|
The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 210°C (158°F to 410°F).
|
309-749-0
|
100801-66-9
|
Carc. 1B; Muta. 1B |
||
|
The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70°C to 120°C (158°F to 248°F).
|
309-748-5
|
100801-65-8
|
Carc. 1B; Muta. 1B |
||
|
The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 120°C (158°F to 248°F).
|
309-745-9
|
100801-63-6
|
Carc. 1B; Muta. 1B |
||
|
233-113-0
|
10035-10-6
|
Press. Gas; Skin Corr. 1A; STOT SE 3 |
|||
|
233-113-0
|
10035-10-6
|
Skin Corr. 1B; STOT SE 3 |
|||
|
233-109-9
|
10034-85-2
|
Press. Gas; Skin Corr. 1A |
|||
|
233-109-9
|
10034-85-2
|
Skin Corr. 1B |
|||
|
204-563-5
|
122-66-7
|
Carc. 1B; Acute Tox. 4 |
|||
|
HNF; HYDRAZINIUM NITROFORMATE
|
414-850-9
|
4682-01-3
|
Expl. 1.1; Self-react. A; Carc. 1B; Acute Tox. 3; Skin Sens. 1 |
||
|
616-584-0
|
7803-57-8
|
yes |
|||
|
STABO-FIX
|
405-030-1
|
148434-03-1
|
Carc. 1B; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
||
|
206-114-9
|
302-01-2
|
Flam. Liq. 3; Carc. 1B; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
yes |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
F Fungi |
|||
|
-
|
-
|
F Fungi |
|||
|
219-698-5
|
2499-95-8
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
257-074-4
|
51235-04-2
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
NATRIUMMETAWOLFRAMAT
|
412-770-9
|
12141-67-2
|
Acute Tox. 4; Eye Dam. 1 |
||
|
BRUN REACTIF 45; BRUNO REATTIVO 45; C.I. REACTIVE BROWN 45; CIBACROM BROWN 1347; CIBACRON BROWN 1347; REACTIVE BRAUN 45
|
401-650-1
|
85665-96-9
|
Skin Sens. 1 |
||
|
C.I. BLEU REACTIF 204; C.I. REACTIVE BLUE 204; REACTIVE BLUE 204; REAKTIV BLAU 204
|
400-050-7
|
85153-92-0
|
Resp. Sens. 1; Skin Sens. 1 |
||
|
RED SF-PE 3534
|
410-180-6
|
157627-99-1
|
Eye Dam. 1 |
||
|
BRIGHTENER SM 1018 CONC.; LEUCOPHOR BCR
|
405-280-1
|
76508-02-6
|
Eye Irrit. 2 |
||
|
PROCION EMERALD H-EXL COLOUR; SUBSTANCE S156718
|
417-250-5
|
151436-99-6
|
Eye Dam. 1; Skin Sens. 1 |
||
|
247-143-7
|
25637-27-8
|
Acute Tox. 4 |
|||
|
-
|
-
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
203-523-4
|
107-83-5
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
209-731-1
|
591-78-6
|
Flam. Liq. 3; Repr. 2; STOT RE 1; STOT SE 3 |
|||
|
203-852-3
|
111-27-3
|
Acute Tox. 4 |
|||
|
211-653-8
|
680-31-9
|
Carc. 1B; Muta. 1B |
|||
|
204-679-6
|
124-09-4
|
Acute Tox. 4; STOT SE 3; Skin Corr. 1B |
|||
|
212-485-8
|
822-06-0
|
Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
|||
|
235-921-9
|
13048-33-4
|
Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
DIRECT RED 227, TETRAMETHYLAMMONIUM SALT
|
405-160-9
|
124537-30-0
|
Acute Tox. 3; Skin Sens. 1 |
||
|
247-094-1
|
25550-51-0
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
AMINAZA TOLFAMATATE
|
418-350-1
|
-
|
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
||
|
243-072-0
|
19438-60-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
260-566-1
|
57110-29-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
256-356-4
|
48122-14-1
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
204-127-4
|
116-15-4
|
Press. Gas; Acute Tox. 4; STOT SE 3 |
|||
|
HEXACONAZOLE
|
413-050-7
|
79983-71-4
|
Acute Tox. 4; Skin Sens. 1 |
||
|
241-010-7
|
16941-12-1
|
Acute Tox. 3; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
|||
|
show/hide
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with tributylphosphine hydrochloride and N-(3-(trimethoxysilyl)propyl)-1,2-ethanediamine
EC / List no:
-
| CAS no:
67924-25-8
Dihydrogen hexachloroplatinate, compound with 1,1,3,3-tetramethyl-1,3-divinyldisiloxane
EC / List no:
258-092-5
| CAS no:
52672-74-9
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane
EC / List no:
271-555-6
| CAS no:
68585-32-0
Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-, reaction products with palladium
EC / List no:
-
| CAS no:
68516-04-1
|
-
|
-
|
Acute Tox. 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
||
|
201-029-3
|
77-47-4
|
Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B |
|||
|
204-273-9
|
118-74-1
|
Carc. 1B; STOT RE 1 |
|||
|
204-129-5
|
116-16-5
|
Acute Tox. 4 |
|||
|
show/hide
|
247-148-4
|
25637-99-4
|
Repr. 2; Lact. |
yes |
|
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
245-737-0
|
23560-59-0
|
Acute Tox. 3 |
|||
|
203-838-7
|
111-14-8
|
Skin Corr. 1B |
|||
|
205-563-8
|
142-82-5
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
204-608-9
|
123-19-3
|
Flam. Liq. 3; Acute Tox. 4 |
|||
|
203-388-1
|
106-35-4
|
Flam. Liq. 3; Acute Tox. 4; Eye Irrit. 2 |
|||
|
203-767-1
|
110-43-0
|
Flam. Liq. 3; Acute Tox. 4 |
|||
|
206-803-4
|
376-06-7
|
yes |
|||
|
213-831-0
|
1024-57-3
|
Carc. 2; Acute Tox. 3; STOT RE 2 |
|||
|
200-962-3
|
76-44-8
|
Carc. 2; Acute Tox. 3; STOT RE 2 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
218-165-4
|
2058-94-8
|
yes |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
12035-71-1
|
Carc. 1A; Muta. 2; STOT RE 1; Skin Sens. 1 |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
HALOXYFOP ETHOXYETHYL EST
|
402-560-5
|
87237-48-7
|
Acute Tox. 4 |
||
|
600-130-3
|
100784-20-1
|
Repr. 1B |
|||
|
TILCOM HTB
|
411-740-2
|
22411-22-9
|
Eye Dam. 1; Skin Sens. 1 |
||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
-
|
-
|
B Bacteria and similar species |
|||
|
620-427-1
|
108173-90-6
|
Acute Tox. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 |
|||
|
200-002-3
|
50-01-1
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
|||
|
GUANIDINIUMBENZOAT
|
429-820-0
|
26739-54-8
|
Acute Tox. 4 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
|||
|
201-964-7
|
90-05-1
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
|||
|
219-468-4
|
2439-99-8
|
Eye Dam. 1 |
|||
|
617-243-9
|
81591-81-3
|
Acute Tox. 4 |
|||
|
213-997-4
|
1071-83-6
|
Eye Dam. 1 |
|||
|
206-058-5
|
298-12-4
|
Eye Dam. 1; Skin Sens. 1B |
|||
|
203-474-9
|
107-22-2
|
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
200-240-8
|
55-63-0
|
Unst. Expl.; Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
|||
|
200-240-8
|
55-63-0
|
Expl. 1.1; Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
|||
|
203-856-5
|
111-30-8
|
Acute Tox. 2; Acute Tox. 3; STOT SE 3; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1A |
|||
|
EW 400; GLUCOPROTAMIN
|
403-950-8
|
164907-72-6
|
Acute Tox. 2; Acute Tox. 4; Skin Corr. 1B |
||
|
278-636-5
|
77182-82-2
|
Repr. 1B; Acute Tox. 4; STOT RE 2 |
|||
|
232-589-7
|
9001-22-3
|
Resp. Sens. 1 |
|||
|
-
|
-
|
Carc. 2 |
|||
|
-
|
-
|
P Parasites |
|||